Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study [Phase 2]
Phase II study results for Zibotentan (ZD4054) in non-small cell lung cancer; the trial completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Iressa as Second Line Therapy in Advanced NSCLC-Asia [Phase 3]
Phase 3 clinical trial update showing Iressa as second-line therapy for advanced non-small cell lung cancer in Asia; study completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update covers the use of carboplatin plus vinorelbine for stage IIIB or IV non-small cell lung cancer in Phase 1/Phase 2…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study of combination chemotherapy plus radiation therapy for stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases [Phase 2]
Phase 2 trial evaluates radiation therapy plus gefitinib or temozolomide in patients with non-small cell lung cancer and brain metastases; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update evaluating gefitinib as first-line therapy followed by gemcitabine and cisplatin in patients with stage III or stage …
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated first-line therapy with carboplatin and paclitaxel plus TLK286 (Telcyta) in advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase I/II trial of RAD001 (everolimus) plus docetaxel in metastatic or recurrent non-small cell lung cancer was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Phase 3 study of icotinib in non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2012-05-23Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase III trial of Tariquidar with Paclitaxel/Carboplatin as first-line therapy in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase III randomized trial evaluating Tariquidar plus Vinorelbine as first-line therapy for stage IIIb/IV non-small cell lung cancer was t…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. [Phase 2]
Phase 2 study evaluating axitinib or bevacizumab in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer [Phase 2]
This report summarizes results from a Phase 2 trial evaluating two methods of combining cetuximab with gemcitabine in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update on induction and maintenance treatment for advanced or metastatic non-squamous non-small cell lung cancer; results were…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating soblidotin for progressive locally advanced or metastatic non-small cell lung cancer has completed enrol…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer [NA]
A clinical trial evaluating chemotherapy combined with whole-body hyperthermia for stage IIIB/IV non-small cell lung cancer; the current sta…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase II single-arm trial of vinflunine as second-line treatment for advanced non-small cell lung cancer has completed enrollment/status. Th…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC [Phase 2]
A Phase II trial evaluating Eloxatin (oxaliplatin) and Alimta (pemetrexed) in combination with Bevacizumab in advanced non-squamous non-smal…
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 open-label study of a GARFT inhibitor in patients with metastatic non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2012-05-08Clinical Trial Update: Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer [Phase 3]
Clinical trial update noting Phase 3 testing of pemetrexed with or without carboplatin for elderly patients with non-squamous non-small cell…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer [Phase 2]
Clinical trial results for Sorafenib (BAY 43-9006) in relapsed non-small cell lung cancer (Phase 2) have been posted following completion of…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC [Phase 2]
A Phase II neoadjuvant trial evaluating dose-dense paclitaxel plus cisplatin for operable Stage II and IIA non-small cell lung cancer has be…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of satraplatin with paclitaxel in patients with advanced non-small cell lung cancer; the study is …
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1b study of volociximab in combination with carboplatin, paclitaxel, and bevacizumab for first-line advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Randomized Gefitinib Trial [Phase 3]
A Phase 3 randomized trial of gefitinib for non-small cell lung cancer has completed.